Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes

Marina Picillo,Emilia Vitale,Antonella Rendina,Aldo Donizetti,Vincenza Aliperti,Maria Francesca Tepedino,Giovanna Dati,Monia Ginevrino,Enza Maria Valente,Paolo Barone
DOI: https://doi.org/10.3233/JAD-200151
Abstract:Background: Mutations in the GRN gene are causative for an autosomal dominant form of frontotemporal dementia. Objective/methods: The objective of the present study is to describe clinical and molecular features of three siblings harboring the GRN deletion NM_002087.3:c.295_308delTGCCCACGGGGCTT, p.(Cys99Profs*15) identified with next generation sequencing. Results: Our patients demonstrated heterogeneous clinical phenotypes, such as progressive supranuclear palsy-like in the proband and the behavioral variant of frontotemporal dementia in the two affected siblings. Progranulin haploinsufficiency was revealed by both gene expression and protein analyses. Conclusion: The pathogenicity of the novel GRN deletion c.295_308del TGCCCACGGGGCTT is confirmed by both functional analysis and segregation in three affected siblings.
What problem does this paper attempt to address?